Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Escalation Safety Study of Urokinase for Thrombolysis in Patients With Acute Ischemic Stroke

NCT07047326 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT07047326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07047326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Escalation Safety Study of Urokinase for Thrombolysis in Patients With Acute Ischemic Stroke
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2025
Completion date
January 2, 2027
Enrollment
24 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke